AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$220M |
| 2 |
RTX Corp
RTX
|
+$218M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$177M |
| 4 |
PNC Financial Services
PNC
|
+$168M |
| 5 |
Medtronic
MDT
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$319M |
| 2 |
Apple
AAPL
|
+$209M |
| 3 |
Booking.com
BKNG
|
+$201M |
| 4 |
Starbucks
SBUX
|
+$153M |
| 5 |
Gilead Sciences
GILD
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.43% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 14.47% |
| 4 | Consumer Discretionary | 11.29% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FFIC
2351
DELISTED
Flushing Financial
FFIC
| $784K | ﹤0.01% |
38,799
-500
| -1% | -$10.2K |
|
|
VIVO
2352
DELISTED
Meridian Bioscience Inc
VIVO
| $783K | ﹤0.01% |
82,537
-9,700
| -11% | -$102K |
|
2353
TechTarget
TTGT
$323M
| $779K | ﹤0.01% |
34,570
-2,530
| -7% | -$58.1K |
|
2354
Globant
GLOB
$1.52B
| $778K | ﹤0.01% |
8,494
-2,216
| -21% | -$220K |
|
2355
GameStop
GME
$9.94B
| $777K | ﹤0.01% |
563,156
-101,400
| -15% | -$110K |
|
|
NSTG
2356
DELISTED
NanoString Technologies, Inc.
NSTG
| $775K | ﹤0.01% |
35,900
| – | – |
|
2357
Vicor
VICR
$8.76B
| $773K | ﹤0.01% |
26,180
-3,320
| -11% | -$102K |
|
|
RESI
2358
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $773K | ﹤0.01% |
66,879
+750
| +1% | +$8.68K |
|
2359
Atara Biotherapeutics
ATRA
$70.4M
| $772K | ﹤0.01% |
2,186
| – | – |
|
|
LBAI
2360
DELISTED
Lakeland Bancorp Inc
LBAI
| $772K | ﹤0.01% |
50,045
-1,500
| -3% | -$23.4K |
|
2361
Wipro
WIT
$19B
| $771K | ﹤0.01% |
422,684
-4,080
| -1% | -$8.01K |
|
|
IMGN
2362
DELISTED
Immunogen Inc
IMGN
| $771K | ﹤0.01% |
318,664
-11,600
| -4% | -$30.8K |
|
2363
Midland States Bancorp
MSBI
$707M
| $766K | ﹤0.01% |
29,420
-2,100
| -7% | -$55.1K |
|
2364
Grupo Aval
AVAL
$5.79B
| $765K | ﹤0.01% |
102,530
| – | – |
|
2365
Cytokinetics
CYTK
$10.8B
| $764K | ﹤0.01% |
67,100
-13,000
| -16% | -$163K |
|
2366
International Seaways
INSW
$4.63B
| $764K | ﹤0.01% |
39,665
| – | – |
|
|
CUTR
2367
DELISTED
Cutera, Inc.
CUTR
| $763K | ﹤0.01% |
26,100
-3,200
| -11% | -$88K |
|
2368
Adtran
ADTN
$730M
| $762K | ﹤0.01% |
67,153
-15,200
| -18% | -$181K |
|
2369
Kinross Gold
KGC
$28.1B
| $761K | ﹤0.01% |
165,360
-2,938
| -2% | -$13.6K |
|
|
SBT
2370
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $761K | ﹤0.01% |
77,944
+3,300
| +4% | +$32.1K |
|
2371
Tidewater
TDW
$3.71B
| $757K | ﹤0.01% |
50,100
| – | – |
|
|
CHS
2372
DELISTED
Chicos FAS, Inc.
CHS
| $754K | ﹤0.01% |
187,200
-8,500
| -4% | -$28.7K |
|
|
AXDX
2373
DELISTED
Accelerate Diagnostics
AXDX
| $747K | ﹤0.01% |
4,021
| – | – |
|
2374
iShares US Healthcare ETF
IYH
$3.46B
| $746K | ﹤0.01% |
19,740
+75
| +0.4% | +$2.89K |
|
2375
Liberty Energy
LBRT
$2.89B
| $744K | ﹤0.01% |
68,700
-450
| -0.7% | -$5.52K |
|
Similar funds
AllianceBernstein's Q3 2019 Portfolio in Review
As of Q3 2019, AllianceBernstein held 3,241 positions worth $161B, down 0.22% from $161B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AllianceBernstein's Q3 2019 filing shows 100 new, 1,235 increased, 1,524 reduced and 89 closed positions. Its largest new stake was Dynatrace: 4,825,272 shares worth $90.1M. The largest sale was Walt Disney, an estimated $319M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2019 buy was Dynatrace: 4,825,272 shares worth $90.1M.
- AllianceBernstein added most to International Flavors & Fragrances in Q3 2019, an estimated $220M increase.
- AllianceBernstein's biggest Q3 2019 reduction was Walt Disney, cutting an estimated $319M.
- AllianceBernstein fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $122M.
- AllianceBernstein's ten largest holdings make up 18% of its $161B portfolio in Q3 2019.
- AllianceBernstein opened 100 new positions and closed 89 in Q3 2019.
- AllianceBernstein's portfolio value fell 0.22% quarter-over-quarter to $161B.
Based on AllianceBernstein's 13F filing for Q3 2019, filed 14 Nov 2019.